메뉴 건너뛰기




Volumn 75, Issue 1, 2010, Pages 82-83

Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; BETA LACTAMASE OXA 23; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; COLISTIN; FLUCONAZOLE; IMIPENEM; MEROPENEM; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TIGECYCLINE; TIMENTIN; UNCLASSIFIED DRUG;

EID: 77951282217     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2010.01.007     Document Type: Letter
Times cited : (23)

References (7)
  • 1
    • 55849106287 scopus 로고    scopus 로고
    • Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania
    • Adams-Haduch J.M., Paterson D.L., Sidjabat H.E., et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicrob Agents Chemother 2008, 52:3837-3843.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 3837-3843
    • Adams-Haduch, J.M.1    Paterson, D.L.2    Sidjabat, H.E.3
  • 2
    • 34250171728 scopus 로고    scopus 로고
    • Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii
    • Peleg A.Y., Adams J., Paterson D.L. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii. Antimicrob Agents Chemother 2007, 51:2065-2069.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 2065-2069
    • Peleg, A.Y.1    Adams, J.2    Paterson, D.L.3
  • 3
    • 62949197844 scopus 로고    scopus 로고
    • In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group
    • Arroyo L.A., Mateos I., González V., Aznar J. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group. Antimicrob Agents Chemother 2009, 53:1295-1296.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1295-1296
    • Arroyo, L.A.1    Mateos, I.2    González, V.3    Aznar, J.4
  • 4
    • 68049114690 scopus 로고    scopus 로고
    • Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea
    • Park Y., Peck K., Cheong H., Chung D.-R., Song J.-H., Ko K. Extreme drug resistance in Acinetobacter baumannii infections in intensive care units, South Korea. Emerg Infect Dis 2009, 15:1325-1327.
    • (2009) Emerg Infect Dis , vol.15 , pp. 1325-1327
    • Park, Y.1    Peck, K.2    Cheong, H.3    Chung, D.-R.4    Song, J.-H.5    Ko, K.6
  • 5
    • 35348821803 scopus 로고    scopus 로고
    • A step closer to extreme drug resistance (XDR) in Gram-negative bacilli
    • Paterson D., Doi Y. A step closer to extreme drug resistance (XDR) in Gram-negative bacilli. Clin Infect Dis 2007, 45:1180-1181.
    • (2007) Clin Infect Dis , vol.45 , pp. 1180-1181
    • Paterson, D.1    Doi, Y.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.